Does ERIBULIN Cause Interstitial lung disease? 171 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 171 reports of Interstitial lung disease have been filed in association with ERIBULIN (eribulin mesylate). This represents 3.4% of all adverse event reports for ERIBULIN.
171
Reports of Interstitial lung disease with ERIBULIN
3.4%
of all ERIBULIN reports
30
Deaths
91
Hospitalizations
How Dangerous Is Interstitial lung disease From ERIBULIN?
Of the 171 reports, 30 (17.5%) resulted in death, 91 (53.2%) required hospitalization, and 7 (4.1%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for ERIBULIN.
What Other Side Effects Does ERIBULIN Cause?
Neutropenia (675)
Malignant neoplasm progression (594)
Myelosuppression (520)
Febrile neutropenia (448)
Neutrophil count decreased (294)
Neuropathy peripheral (290)
White blood cell count decreased (289)
Pyrexia (275)
Disease progression (211)
Fatigue (209)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which ERIBULIN Alternatives Have Lower Interstitial lung disease Risk?
ERIBULIN vs ERLOTINIB
ERIBULIN vs ERTAPENEM
ERIBULIN vs ERTUGLIFLOZIN PIDOLATE
ERIBULIN vs ERYTHROMYCIN
ERIBULIN vs ERYTHROMYCIN ETHYLSUCCINATE